eli lilly glp 1 market share is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Eli Lilly: No Big Gap

Dysesthesia: Retatrutide's Unique Issue Dysesthesia (abnormal touch sensations) affects 1 in 5 retatrutide patients at highest dose

Mannone et al.3 identified three major dermoscopic patterns in benign mucosal melanotic macule, known as parallel pattern, structureless pattern and reticular-like pattern3

The Wegovy Pill delivers the identical semaglutide molecule

Retatrutide has a half-life of approximately 6 days, making once-weekly dosing sufficient

People often describe it as berberine belly, but the real point is simple: your gut may not love it

Weight loss reduces the mechanical load on bones, which can lead to lower bone density and, in some people such as those who are postmenopausal, as well as people over age 65 an increased risk of fracture